Bone Biologics (BBLG) Assets Average (2013 - 2025)

Bone Biologics (BBLG) has 13 years of Assets Average data on file, last reported at $6.1 million in Q4 2025.

• Assets Average for Q4 2025 came in at $6.1 million, up 53.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.1 million (up 53.23% YoY), and the FY2025 annual result was $4.8 million, up 27.09% from the prior year.
• Assets Average retreated to $6.1 million in Q4 2025 per BBLG's latest filing, from $6.7 million in the prior quarter.
• Over five years, Assets Average peaked at $7.6 million in Q1 2023 and troughed at $28415.5 in Q3 2021.
• A 5-year average of $4.7 million and a median of $5.1 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average jumped 19009.04% in 2022, then plunged 51.18% in 2024.
• A 5-year view of Assets Average shows it stood at $3.4 million in 2021, then jumped by 103.58% to $6.8 million in 2022, then plunged by 36.38% to $4.4 million in 2023, then fell by 9.03% to $4.0 million in 2024, then surged by 53.23% to $6.1 million in 2025.
• Business Quant data shows BBLG's Assets Average at $6.1 million in Q4 2025, $6.7 million in Q3 2025, and $5.1 million in Q2 2025.